研究者詳細 - 藤井　伸治

論文 - 藤井　伸治

分割表示 165 件中 81 - 100 件目／全件表示 >>

Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study 査読

Nishimura Y, Hanayama Y, Fujii N, Kondo E, Otsuka F.

Intern Med J. 50 ( 2 ) 184 - 191 2020年2月

Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation 査読

Seike K, Fujii N, Asano N, Ohkuma S, Hirata Y , Fujii K, Sando Y, Nakamura M, Naito K , Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka K, Tsubaki K, Otsuka F , Maeda Y.

Transfusion 60 ( 3 ) 473 - 478 2020年1月

Prospective Phase 2 Study of Umbilical Cord Blood Transplantation in Adult Acute Leukemia and Myelodysplastic Syndrome 査読

Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Kohno A, Onishi Y, Fukuhara N, Kasai M, Fujii N, Yokoyama H, Iida H, Kanemura N, Fujieda A, Ago H, Tsutsumi Y, Nakamura F, Yago K, Moriuchi Y, Ota S, Ohashi H, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.

Biol Blood Marrow Transplant. 26 ( 1 ) 139 - 144 2020年1月

Chemotherapy Improved Pulmonary Arterial Hypertension in a Patient with Chronic-Active Epstein-Barr Virus Infection 査読

Akagi S, Miki T, Sando Y, Fujii N, Sarashina T, Nakamura K, Ito H.

Int Heart J. 61 ( 1 ) 191 - 194 2020年1月

Macrophage Elimination in Bone Marrow by Dexamethasone Palmitate is Associated with Successful Engraftment in Patients with Hemophagocytic Syndrome. 査読

Sugiura H, Matsuoka K, Matsuda M, Ikegawa S, Inomata T, Kuroi T, Asano T,Yoshida S, Nishimori H, Fujii K, Fujii N, Maeda Y.

International Journal of Hematology. 110 ( 2 ) 260 - 262 2019年8月

Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels. 査読国際誌

Hiroyuki Sugiura, Ken-Ichi Matsuoka, Yasuhisa Sando, Yusuke Meguri, Shuntaro Ikegawa, Makoto Nakamura, Miki Iwamoto, Takanori Yoshioka, Takeru Asano, Eisei Kondo, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 58 ( 4 ) 472 - 474 2019年8月

記述言語：英語掲載種別：研究論文（学術雑誌）

Mogamulizumab (Mog), a humanized anti-CCR4 antibody, provides an important treatment option for relapsed/refractory adult T cell leukemia/lymphoma. However, administration of Mog before allogenic hematopoietic stem cell transplantation has been reported to be a risk factor for severe acute graft-versus-host disease (GVHD). The etiological hypothesis is Mogamulizumab may eradicate CCR4-positive regulatory T cells (Tregs). Theoretically, Treg homeostasis and course of GVHD can be affected by plasma exchange (PE) with decreasing plasma Mog concentration. Here, we present a case of severe acute GVHD after pretransplantation Mog, in which PE was performed for liver failure. As a result, plasma Mog concentration was decreased but it did not lead to the prompt elevation of Treg levels in peripheral blood and clinical responses of GVHD were limited to partial remission. Our case suggests that recovery of donor-derived Treg in the acute phase after HSCT is multifactorial and the single procedure of PE-based Mog depletion does not necessarily warrant the quick restoration of Treg homeostasis.

DOI： 10.1016/j.transci.2019.05.011

PubMed

researchmap

Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels. 査読

Sugiura H, Matsuoka K, Sando Y, Meguri Y, Ikegawa S, Nakamura M, Iwamoto M, Yoshioka T, Asano T, Kondo E, Fujii K, Fujii N, Maeda Y.

Transfusion and Apheresis Science. S1473-0502 ( 19 ) 30123 - 30125 2019年7月

High dose chemotherapy with autologous stem cell transplantation in primary central nervous system lymphoma: Data from the japan society for hematopoietic cell transplantation (JSHCT) registry 査読

Kondo Eisei, Ikeda Takashi, Izutsu Koji, Chihara Dai, Shimizu-Koresawa Risa, Fujii Nobuharu, Sakai Tomoyuki, Kondo Tadakazu, Kubo Kohmei, Kato Yuichi, Akasaka Takashi, Fukuda Takahiro, Ichinohe Tatsuo, Atsuta Yoshiko, Suzumiya Junji, Suzuki Ritsuro

BONE MARROW TRANSPLANTATION 54 453 - 455 2019年7月

High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry 査読

Kondo E, Ikeda T, Izutsu K, Chihara D, Shimizu-Koresawa R, Fujii N, Sakai T, Kondo T, Kubo K, Kato Y, Akasaka T, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J, Suzuki R; Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 25 ( 5 ) 899 - 905 2019年5月

Salvage Haploidentical Transplantation Using Low-dose ATG for Early Disease Relapse after First Allogeneic Transplantation: A Retrospective Single-center Review 査読

Okamoto S, Matsuoka KI, Sakamoto M, Usui Y, Fujiwara Y, Kondo T, Tani K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Maeda Y.

Acta Med Okayama. 73 ( 2 ) 161 - 171 2019年4月

Neurolymphomatosis in the cauda Equina Diagnosed by an Open Biopsy. 査読

Sasaki R, Ohta Y, Yamada Y, Tadokoro K, Takahashi Y, Sato K, Shang J, Takemoto M, Hishikawa N, Yamashita T, Yasuhara T, Date I, Ikegawa S, Fujii N, Abe K.

Intern Med 57 ( 23 ) 3463 - 3465 2018年12月

Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation 査読

Makoto Nakamura, Nobuharu Fujii, Kazuyoshi Shimizu , Shuntaro Ikegawa, Keisuke Seike, Tomoko Inomata, Yasuhisa Sando, Keiko Fujii, Hisakazu Nishimori, Ken-ichi Matsuoka, Hiroshi Morimatsu , Yoshinobu Maeda

International Journal of Hematology 108 ( 6 ) 622 - 629 2018年12月

抗Fybに加え新たに抗KANNOを産生した1症例査読

池田亮, 小郷博昭, 浅野尚美, 閘結稀, 清家圭介, 三道康永, 中村真, 高木尚江, 藤井敬子, 藤井伸治, 大塚文男

日本輸血細胞治療学会誌 64 ( 6 ) 829 - 830 2018年12月

Villous atrophy in the terminal ileum is a specific endoscopic finding correlated with histological evidence and poor prognosis in acute graft-versus-host disease after allo-hematopoietic stem cell transplantation. 査読国際誌

Sugihara Y, Hiraoka S, Fujii N, Takashima S, Yamasaki Y, Inokuchi T, Takahara M, Kuwaki K, Harada K, Tanaka T, Okada H.

BMC Gastroenterol. 18 ( 1 ) 111 - 111 2018年7月

Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study. 査読国際誌

Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R.

Transfus Med Rev 2018年6月

自己血輸血の変遷貯血式・希釈式・回収式症例数と時代背景を顧みて

藤井敬子, 高木尚江, 清家圭介, 三道康永, 中村真, 閘結稀, 池田亮, 浅野尚美, 小郷博昭, 藤井伸治, 大塚文男

日本輸血細胞治療学会誌 64 ( 2 ) 442 - 442 2018年4月

同種造血幹細胞移植後の好中球減少患者に対する顆粒球輸注療法

藤井伸治, 池川俊太郎, 藤井敬子, 佐伯恭昌, 廻勇輔, 浅田騰, 西森久和, 松岡賢市, 大塚文男, 前田嘉信

日本輸血細胞治療学会誌 64 ( 2 ) 453 - 453 2018年4月

Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis. 国際誌

Shuntaro Ikegawa, Nobuharu Fujii, Koh Tadokoro, Kota Sato, Miki Iwamoto, Masayuki Matsuda, Tomoko Inomata, Hiroyuki Sugiura, Takeru Asano, Shohei Yoshida, Hisakazu Nishimori, Ken-Ichi Matsuoka, Yoshinobu Maeda

Transplant infectious disease : an official journal of the Transplantation Society 20 ( 2 ) e12850 2018年4月

記述言語：英語掲載種別：研究論文（学術雑誌）

A 52-year-old man suffered from progressive multifocal leukoencephalopathy (PML) after human leukocyte antigen (HLA)-haploidentical transplantation with post-transplantation cyclophosphamide (PTCY). Mirtazapine, mefloquine, and cytarabine failed to improve his symptoms, and he finally died 4.5 months after PML onset. This is the first case report of a patient with PML after HLA-haploidentical transplantation with PTCY. Although T-cell replete HLA-haploidentical transplantation with PTCY has enabled early immune reconstitution, PML should be considered if a patient's mental condition deteriorates.

DOI： 10.1111/tid.12850

PubMed

researchmap

Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis. 査読

Ikegawa S, Fujii N, Tadokoro K, Sato K, Iwamoto M, Matsuda M, Inomata T, Sugiura H, Asano T, Yoshida S, Nishimori H, Matsuoka KI, Maeda Y.

Transpl Infect Dis 20 ( 2 ) e12850 - e12850 2018年1月

Mild renal dysfunction defined by creatinine clearance rate has limited impact on clinical outcomes after allogeneic hematopoietic stem cell transplantation. 査読

Ikegawa S, Matsuoka KI, Inomata T, Ikeda N, Sugiura H, Kuroi T, Asano T, Yoshida S, Nishimori H, Fujii N, Kondo E, Maeda Y, Tanimoto M.

International Journal of Hematology 107 ( 5 ) 568 - 577 2018年1月

　前のページ - 次のページ　

<藤井 伸治>

論文 - 藤井 伸治

<藤井　伸治>

論文 - 藤井　伸治